Additional file 1: of Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy â a systematic approach to identify and characterize data sources

Daien, Vincent; Eldem, Bora; Talks, James; Korobelnik, Jean-Francois; Mitchell, Paul; Finger, Robert; Sakamoto, Taiji; Wong, Tien; Evuarherhe, Obaro; Carter, Gemma; Carrasco, Joao

doi:10.6084/m9.figshare.9993815.v1

12886_2019_1208_MOESM1_ESM.docx (32.45 kB)

Additional file 1: of Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy â a systematic approach to identify and characterize data sources

journal contribution

posted on 2019-10-17, 04:59 authored by Vincent Daien, Bora Eldem, James Talks, Jean-Francois Korobelnik, Paul Mitchell, Robert Finger, Taiji Sakamoto, Tien Wong, Obaro Evuarherhe, Gemma Carter, Joao Carrasco

Table S1. Data sources and accessibility. (DOCX 32 kb)

Funding

Bayer

History

Usage metrics

Keywords

Retinal diseases Age-related macular degeneration Choroidal neovascularization Diabetic macular edema Retinal vein occlusion Anti-VEGF Real-world data

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC